SCHEMBL1248728

SCHEMBL1248728

CC(O)C(O)(O)CO.OCC(CO)(CO)CO

nearest known ligand 0.36

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.36
TSHR P16473 2/20 0.36
TDP1 Q9NUW8 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2501832 0.91
SCHEMBL28222497 0.80 ALDH1A1 (0.37) ALDH1A1TSHRTDP1
Isopropyl Alcohol SCHEMBL28439673 0.78 ALDH1A1 (0.46) ALDH1A1TSHRTDP1
Propylene Glycol SCHEMBL694327 0.73 TDP1 (0.67) ALDH1A1TSHRTDP1
SCHEMBL6153976 0.71
Glycerin SCHEMBL23111588 0.69 LMNA (0.64) ALDH1A1TSHRTDP1
Glycerin SCHEMBL3573387 0.69 LMNA (0.64) ALDH1A1TSHRTDP1
SCHEMBL7037853 0.69
Glycerin SCHEMBL6285644 0.69 LMNA (0.64) ALDH1A1TSHRTDP1
Isobutanol SCHEMBL30450802 0.69 TSHR (0.64) ALDH1A1TSHRTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2285866-A2 BIOCOMPATIBLE CROSSLINKED HYDROGELS, DRUG-LOADED HYDROGELS AND METHODS OF USING THE SAME Angiotech Pharmaceuticals, Inc. (CA) 2011-02-23 EP claimed
EP-2285866-A2 BIOCOMPATIBLE CROSSLINKED HYDROGELS, DRUG-LOADED HYDROGELS AND METHODS OF USING THE SAME Angiotech Pharmaceuticals, Inc. (CA) 2011-02-23 EP disclosed
US-7514463-B2 Lonidamine analogues and their use in male contraception and cancer treatment UNIVERSITY OF KANSAS (US) 2009-04-07 US disclosed